The biological effect of cytokines is mainly determined by the cytokine-receptor interaction, which is modulated by the concentration and the activity of cytokines and/or their receptors. Because ␣v-containing integrins can bind to and/or activate latent TGF-, these integrins have been thought to be involved in the pathogenesis of fibrotic disorders. Our recent observations that ␣v5 is up-regulated in scleroderma fibroblasts and that the transient overexpression of ␣v5 increases the human ␣2(I) collagen gene expression in normal fibroblasts suggest the involvement of ␣v5 in the self-activation system in scleroderma fibroblasts. In this study, we established stable transfectants with ␣v5 using normal dermal fibroblasts and demonstrated that such cells differentiated into myofibroblasts by the stimulation of autocrine TGF-. This observation is explained by 1) ␣v5 recruiting latent TGF-1 on the cell surface, 2) endogenous active TGF- localizing on the cell surface, and 3) ␣v5 interacting with TGF- receptors. Furthermore, blockade of ␣v5 reversed the myofibroblastic phenotype in scleroderma fibroblasts. These data identify a novel mechanism for the establishment of autocrine TGF- signaling in dermal fibroblasts by the up-regulation of ␣v5 and suggest the possibility of regulating fibrotic disorders, especially scleroderma, by targeting this integrin.